Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor buparlisib (BKM120) in recurrent glioblastoma Meeting Abstract


Authors: Wen, P. Y.; Yung, W. K. A.; Mellinghoff, I. K.; Ramkissoon, S.; Alexander, B. M.; Rinne, M. L.; Colman, H.; Omura, A. M. P.; Deangelis, L. M.; Gilbert, M. R.; De Groot, J. F.; Cloughesy, T. F.; Chi, A. S.; Lee, E. Q.; Nayak, L.; Batchelor, T.; Chang, S. M.; Prados, M.; Reardon, D. A.; Ligon, K. L.
Abstract Title: Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor buparlisib (BKM120) in recurrent glioblastoma
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202685
PROVIDER: wos
Notes: Meeting Abstract: 2019 -- Source: Wos